COMPANY

COMPANY

Korea Zinc Files Complaint Against MBK and Young Poong for Alleged Fraudulent Trading: Reporter Kim Jisun 2024.11.22

LG Chem Secures Up to 100,000 Tons of Lithium Supply from ExxonMobil Over 10 Years: Reporter Kim Jisun 2024.11.22

North Korea Confirmed to Have Stolen ₩58 Billion Worth of Ethereum from Upbit: First Official Verification by Korean Police: Reporter Kim Jisun 2024.11.22

Lotte Denies 'Crisis' Rumors: "Real Estate and Deposits Worth 71 Trillion Won": Reporter Kim Jisun 2024.11.22

Baek Jong-won's The Born Korea Falls Below 40,000 KRW for the First Time Since Listing: Reporter Kim SangJin 2024.11.22

Controversy Erupts Over HL Holdings' Donation of Treasury Shares to Foundation, Criticized for Damaging Shareholder Value: Reporter Kim SangJin 2024.11.22

Harim Group Faces Disclosure Controversy Over Inflated Seasoned Food Sales in Q2 Report: 김영택 기자 2024.11.22

DB Financial Investment Acquires Full Ownership of DB Asset Management: Reporter Kim SangJin 2024.11.22

HD Hyundai Heavy Industries Reaches Dramatic Labor Agreement, Basic Salary to Rise by 130,000 KRW: Reporter Kim SangJin 2024.11.22

EU Expected to Approve Korean Air-Asiana Merger by End of the Month: Reporter Kim SangJin 2024.11.22

Celltrion Announces Additional 100 Billion KRW Share Buyback: Reporter Kim SangJin 2024.11.22

CJ CheilJedang to Invest 800 Billion KRW in New Food Factories in Hungary and South Dakota: Reporter Kim SangJin 2024.11.22

Hanwha Aerospace Completes Acquisition of 95% Stake in Singapore's Dyna-Mac: Reporter Kim Jisun 2024.11.22

SK Square Announces Plans to Boost Corporate Value with 2 Trillion KRW Shareholder Return Program: Reporter Kim Jisun 2024.11.22

SKC Subsidiary Appsolix Secures $100 Million in U.S. R&D Grants: Reporter Kim Jisun 2024.11.22

Kyobo Securities CEO Park Bong-kwon: "No Plans for Branch Consolidation or Workforce Restructuring": Reporter Kim SangJin 2024.11.21

Namyang Dairy Sees Drop on First Trading Day After Stock Split, With Intraday Dip of 11%: Reporter Kim SangJin 2024.11.21

DI Dongil Prosecuted for Violating Accounting Standards: Reporter Kim SangJin 2024.11.21

Hanmi Pharmaceutical to File Counterclaims Against Hanmi Science CEO for False Accusations: Reporter Kim SangJin 2024.11.21

CJ Bioscience Hits Upper Limit for Second Day Amid Sale Speculation: Reporter Kim SangJin 2024.11.21